Free Trial

Virpax Pharmaceuticals (VRPX) SEC Filings & 10K Form

Virpax Pharmaceuticals logo
$0.33 +0.01 (+4.30%)
(As of 12/20/2024 05:51 PM ET)

Recent Virpax Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/18/2024
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:15 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
4:29 PM
Virpax Pharmaceuticals (Filer)
Form DEF 14A
11/29/2024
5:39 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:01 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:31 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
5:06 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:20 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
11:15 PM
Virpax Pharmaceuticals (Filer)
Form EFFECT
11/07/2024
4:01 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/28/2024
3:08 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/18/2024
4:28 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/10/2024
4:07 PM
Virpax Pharmaceuticals (Filer)
Form 10-K/A
10/10/2024
4:08 PM
Virpax Pharmaceuticals (Filer)
Form 10-K/A
10/09/2024
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 8-K/A
10/04/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:12 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
8:05 AM
Virpax Pharmaceuticals (Filer)
Form S-1/A
08/13/2024
6:35 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:26 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/26/2024
3:31 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
6:45 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:40 PM
Su Judy (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/15/2024
7:00 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:09 PM
Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
3:10 PM
Field Katharyn (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
11:48 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
3:00 PM
Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
3:01 PM
Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
3:02 PM
Dhaliwal Jatinder (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:03 PM
Herman Gary L (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM
Virpax Pharmaceuticals (Filer)
Form DEFA14A
07/08/2024
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
4:09 PM
Virpax Pharmaceuticals (Filer)
Form DEF 14A
06/12/2024
4:11 PM
Virpax Pharmaceuticals (Filer)
Form ARS
05/14/2024
11:15 PM
Virpax Pharmaceuticals (Filer)
Form EFFECT
05/13/2024
4:30 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
05/13/2024
3:02 PM
Virpax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
8:54 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
This is the worst sign for the U.S. stock market in 50 years (Ad)

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.
04/30/2024
6:35 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
4:15 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
04/18/2024
3:17 PM
Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/26/2024
7:15 AM
Virpax Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
5:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
5:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
3:05 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:22 PM
Floyd Eric (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:22 PM
Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:23 PM
Sendrow Jerrold (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:23 PM
Dubin Michael F (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:24 PM
Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:25 PM
Jambulingam Thani (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:25 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:26 PM
Singh Vanila (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
9:11 AM
SABBY MANAGEMENT, LLC (Filed by)
Virpax Pharmaceuticals (Subject)
Form SC 13G/A
12/29/2023
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRPX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners